Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
D000818:Animals; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000473:pathology; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000473:pathology; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D009243:NAD / Q000378:metabolism / Q000627:therapeutic use*; D009249:NADP / Q000378:metabolism / Q000627:therapeutic use*; D009336:Necrosis / Q000188:drug therapy*; D009536:Niacinamide / Q000627:therapeutic use*; D010179:Pancreas / Q000473:pathology; D051381:Rats; D013311:Streptozocin / Q000037:antagonists & inhibitors; D013997:Time Factors
D009243:NAD; D009536:Niacinamide; D009249:NADP; D013311:Streptozocin